Abstract
BackgroundAdalimumab (ADA) has been shown to be safe and effective in patients (pts) with long-standing rheumatoid arthritis (RA).1 Patients with RA are candidates for routine vaccination with inactivated agents, in...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have